CXCL8 and chronic obstructive pulmonary disease: Rapamycin, a immunosuppressant that inhibits the activity of mTOR, increased GC sensitivity in PBMCs from COPD patients through decreased phosphorylation of p70 S6 kinase, and concomitant reduction in c-JUN and cytokine (IL-8) levels.